Sigyn Therapeutics, Inc. (SIGY) — Operating Income

Annual figures by fiscal year, from SEC filings.

2014: -$387.5K2015: -$2.25M2017: -$2.03M2018: -$1.00M2019: -$518.0K2020: -$916.4K2021: -$2.01M2022: -$2.15M2023: -$2.46M2024: -$2.52M-$2.52M
2014Operating Income (USD)2024
Fiscal YearOperating IncomeChange YoY
2024-$2.52M-2.6%
2023-$2.46M-14.3%
2022-$2.15M-6.9%
2021-$2.01M-119.1%
2020-$916.4K-76.9%
2019-$518.0K+48.4%
2018-$1.00M+50.5%
2017-$2.03M
2015-$2.25M-481.4%
2014-$387.5K